People who take semaglutide are at an increased risk of medullary thyroid carcinoma (thyroid cancer), acute pancreatitis, gallbladder disease, hypoglycemia (low blood sugar), acute kidney injury, increased heart rate, diabetic retinopathy complications, depression, and suicidal thoughts
Providers at Found are generally board-certified in obesity medicine or have specific training in metabolic health, which means the clinical evaluation tends to be more nuanced than platforms that rely primarily on general practitioners or nurse practitioners
Distinct antigen expression related to DNA ploidy in a case of biphenotypic leukemia
Kidney problems/kidney failure vomiting, nausea, and diarrhea can cause dehydration and kidney issues, and may worsen pre-existing kidney conditions
Moreover, physicians must acquire a comprehensive understanding of the distinctive characteristics of adverse reactions that may arise from Simeglutide administration via different routes